Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline
Background: Evidence-based guidelines are needed for effective delivery of home oxygen therapy to appropriate patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD).Methods: The multidisciplinary panel created six research questions using a modified Delphi approach. A systematic review of the literature was completed, and the Grading of Recommendations Assessment, Development and Evaluation approach was used to formulate clinical recommendations.Recommendations: The panel found varying quality and availability of evidence and made the following judgments: 1) strong recommendations for long-term oxygen use in patients with COPD (moderate-quality evidence) or ILD (low-quality evidence) with severe chronic resting hypoxemia, 2) a conditional recommendation against long-term oxygen use in patients with COPD with moderate chronic resting hypoxemia, 3) conditional recommendations for ambulatory oxygen use in patients with COPD (moderate-quality evidence) or ILD (low-quality evidence) with severe exertional hypoxemia, 4) a conditional recommendation for ambulatory liquid-oxygen use in patients who are mobile outside the home and require >3 L/min of continuous-flow oxygen during exertion (very-low-quality evidence), and 5) a recommendation that patients and their caregivers receive education on oxygen equipment and safety (best-practice statement).Conclusions: These guidelines provide the basis for evidence-based use of home oxygen therapy in adults with COPD or ILD but also highlight the need for additional research to guide clinical practice.
| Errataetall: |
ErratumIn: Am J Respir Crit Care Med. 2021 Apr 15;203(8):1045-1046. - PMID 33856281 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:202 |
|---|---|
| Enthalten in: |
American journal of respiratory and critical care medicine - 202(2020), 10 vom: 15. Nov., Seite e121-e141 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jacobs, Susan S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chronic obstructive pulmonary disease |
|---|
| Anmerkungen: |
Date Completed 01.12.2020 Date Revised 30.03.2024 published: Print ErratumIn: Am J Respir Crit Care Med. 2021 Apr 15;203(8):1045-1046. - PMID 33856281 Citation Status MEDLINE |
|---|
| doi: |
10.1164/rccm.202009-3608ST |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317529617 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317529617 | ||
| 003 | DE-627 | ||
| 005 | 20240330233702.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1164/rccm.202009-3608ST |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1356.xml |
| 035 | |a (DE-627)NLM317529617 | ||
| 035 | |a (NLM)33185464 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jacobs, Susan S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.12.2020 | ||
| 500 | |a Date Revised 30.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumIn: Am J Respir Crit Care Med. 2021 Apr 15;203(8):1045-1046. - PMID 33856281 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Background: Evidence-based guidelines are needed for effective delivery of home oxygen therapy to appropriate patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD).Methods: The multidisciplinary panel created six research questions using a modified Delphi approach. A systematic review of the literature was completed, and the Grading of Recommendations Assessment, Development and Evaluation approach was used to formulate clinical recommendations.Recommendations: The panel found varying quality and availability of evidence and made the following judgments: 1) strong recommendations for long-term oxygen use in patients with COPD (moderate-quality evidence) or ILD (low-quality evidence) with severe chronic resting hypoxemia, 2) a conditional recommendation against long-term oxygen use in patients with COPD with moderate chronic resting hypoxemia, 3) conditional recommendations for ambulatory oxygen use in patients with COPD (moderate-quality evidence) or ILD (low-quality evidence) with severe exertional hypoxemia, 4) a conditional recommendation for ambulatory liquid-oxygen use in patients who are mobile outside the home and require >3 L/min of continuous-flow oxygen during exertion (very-low-quality evidence), and 5) a recommendation that patients and their caregivers receive education on oxygen equipment and safety (best-practice statement).Conclusions: These guidelines provide the basis for evidence-based use of home oxygen therapy in adults with COPD or ILD but also highlight the need for additional research to guide clinical practice | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a chronic obstructive pulmonary disease | |
| 650 | 4 | |a hypoxemia | |
| 650 | 4 | |a interstitial lung disease | |
| 650 | 4 | |a mobility | |
| 650 | 4 | |a quality of life | |
| 700 | 1 | |a Krishnan, Jerry A |e verfasserin |4 aut | |
| 700 | 1 | |a Lederer, David J |e verfasserin |4 aut | |
| 700 | 1 | |a Ghazipura, Marya |e verfasserin |4 aut | |
| 700 | 1 | |a Hossain, Tanzib |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Ai-Yui M |e verfasserin |4 aut | |
| 700 | 1 | |a Carlin, Brian |e verfasserin |4 aut | |
| 700 | 1 | |a Drummond, M Bradley |e verfasserin |4 aut | |
| 700 | 1 | |a Ekström, Magnus |e verfasserin |4 aut | |
| 700 | 1 | |a Garvey, Chris |e verfasserin |4 aut | |
| 700 | 1 | |a Graney, Bridget A |e verfasserin |4 aut | |
| 700 | 1 | |a Jackson, Beverly |e verfasserin |4 aut | |
| 700 | 1 | |a Kallstrom, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Knight, Shandra L |e verfasserin |4 aut | |
| 700 | 1 | |a Lindell, Kathleen |e verfasserin |4 aut | |
| 700 | 1 | |a Prieto-Centurion, Valentin |e verfasserin |4 aut | |
| 700 | 1 | |a Renzoni, Elisabetta A |e verfasserin |4 aut | |
| 700 | 1 | |a Ryerson, Christopher J |e verfasserin |4 aut | |
| 700 | 1 | |a Schneidman, Ann |e verfasserin |4 aut | |
| 700 | 1 | |a Swigris, Jeffrey |e verfasserin |4 aut | |
| 700 | 1 | |a Upson, Dona |e verfasserin |4 aut | |
| 700 | 1 | |a Holland, Anne E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of respiratory and critical care medicine |d 1994 |g 202(2020), 10 vom: 15. Nov., Seite e121-e141 |w (DE-627)NLM074657305 |x 1535-4970 |7 nnns |
| 773 | 1 | 8 | |g volume:202 |g year:2020 |g number:10 |g day:15 |g month:11 |g pages:e121-e141 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1164/rccm.202009-3608ST |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 202 |j 2020 |e 10 |b 15 |c 11 |h e121-e141 | ||